J. Kotzerke

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.

Florian Moog, Markus Bangerter, C. G. Diederichs et al. · Radiology · 1997 · 312 citations

Medicine, Nuclear Medicine, Radiology +15

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.

Florian Moog, Markus Bangerter, J. Kotzerke et al. · Journal of Clinical Oncology · 1998 · 277 citations

Medicine, Nuclear Medicine, Oncology +17

Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease

Markus Bangerter, Florian Moog, Inga Buchmann et al. · Annals of Oncology · 1998 · 246 citations · Full text

Medicine, Nuclear Medicine, Radiology +14

Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.

M. Schulte, D. Brecht-Krauß, Mathias Werner et al. · PubMed · 1999 · 205 citations

Medicine, Oncology, Surgery +14

Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET.

M. Schulte, D. Brecht-Krauß, B Heymer et al. · PubMed · 2000 · 180 citations

Medicine, Nuclear Medicine, Radiology +17